Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Alternative Investments Group

Founders Flinn Flexer

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$29M
Portfolio companies 1
Rounds per year 0.04
Lead investments 0
Exits 1
Key employees 9
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
Summary

In 1996 was created Alternative Investments Group, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Southport.

The usual cause for the fund is to invest in rounds with more than 10 partakers. Despite the Alternative Investments Group, startups are often financed by Scottish Equity Partners, Excalibur Fund Managers. The meaningful sponsors for the fund in investment in the same round are UOB Venture, Temasek Holdings, Societe Generale Asset Management. In the next rounds fund is usually obtained by Scottish Equity Partners.

This organization was formed by Flinn Flexer. Besides them, we counted 9 critical employees of this fund in our database.

Among the most successful fund investment fields, there are Pharmaceutical, Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Cyclacel Pharmaceuticals For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2004. The higher amount of exits for fund were in 2006. The fund is constantly included in less than 2 deals per year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Alternative Investments Group:
Typical Co-investors
Alternative Investments Group is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Alternative Investments Group:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Alternative Investments Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 29M
Rounds per year 0.04
Peak activity year 2004
Lead investments 0
Exits 1
Group Appearance index 1.00
Crunchbase icon

Content report

The following text will be sent to our editors: